During neoplasm development, TGF-β signalling is disrupted and non-canonical, SMAD-independent pathways are promoted: mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3Κ)/Akt, and Rho/Rho-associated protein kinase (ROCK). Here, TGFB1 is linked to neoplasm.